Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Dec;87(12):1210-7.
doi: 10.1111/j.1349-7006.1996.tb03135.x.

Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis

Affiliations

Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis

Y Kanai et al. Jpn J Cancer Res. 1996 Dec.

Abstract

In order to clarify the significance of DNA methylation in both earlier and later stages of hepatocarcinogenesis, the DNA methylation state on chromosome 16, on which loss of heterozygosity (LOH) has frequently been detected in human hepatocellular carcinomas (HCCs), was examined. DNA from primary HCCs and tissues showing chronic hepatitis and liver cirrhosis, which are considered to be precancerous conditions, was analyzed by digestion with methylation-sensitive and non-sensitive restriction enzymes. DNA hypermethylation at the D16S32, tyrosine aminotransferase (TAT) and D16S7 loci and hypomethylation at the D16S4 locus were detected in 18%, 58%, 20% and 48% of examined HCCs, respectively. Aberrant DNA methylation occurred more frequently in advanced HCCs than in early HCCs. Moreover, DNA hypermethylation at the D16S32, TAT and D16S7 loci was frequently observed in chronic hepatitis and liver cirrhosis. The incidence of DNA hypermethylation was higher than that of LOH (42% at the TAT locus). These data suggest that DNA hypermethylation might predispose the locus to allelic loss. Aberrant DNA methylation is a significant change which may participate in the early developmental stages of HCCs.

PubMed Disclaimer

References

    1. ) Tsuda , H. , Hirohashi , S. , Shimosato , Y. , Terada , M. and Hasegawa , H.Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma . Gastroenterology , 95 , 1664 – 1666 ( 1988. ). - PubMed
    1. ) Yasui , H. , Hino , O. , Ohtake , K. , Machinami , R. and Kitagawa , T.Clonal growth of hepatitis B virus‐integrated hepatocytes in cirrhotic liver nodule . Cancer Res. , 52 , 6810 – 6814 ( 1992. ). - PubMed
    1. ) Kanai , T. , Hirohashi , S. , Upton , M. P. , Noguchi , M. , Kishi , K. , Makuuchi , M. , Yamasaki , S. , Hasegawa , H. , Takayasu , K. , Moriyama , N. and Shimosato , Y.Pathology of small hepatocellular carcinoma: a proposal for a new gross classification . Cancer , 60 , 810 – 819 ( 1987. ). - PubMed
    1. ) Sakamoto , M. , Hirohashi , S. and Shimosato , Y.Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma . Hum. Pathol. , 22 , 172 – 178 ( 1991. ). - PubMed
    1. ) Wang , H. P. and Rogler , C. E.Deletion in human chromosome arm 11p and 13q in primary hepatocellular carcinoma . Cytogenet. Cell Genet. , 48 , 72 – 78 ( 1988. ). - PubMed

Publication types

LinkOut - more resources